• Study of abemaciclib and its connection to severe diarrhea in patients with hormone receptor-positive breast cancer at high risk of return

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • A Study of Watchful Waiting After Chemotherapy and Radiotherapy Compared to Surgery for Patients with Early Rectal Cancer Using Capecitabine

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    France Italy The Netherlands
  • Testing the effectiveness and safety of remimazolam, ketamine, and propofol for rapid sequence induction in patients at risk of aspiration

    Not yet recruiting

    2 1 1 1
    France
  • Study of drug combination with radiotherapy versus radiotherapy alone for locally advanced rectal cancer in patients 75 years and older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of cemiplimab with or without chemotherapy for non-small cell lung cancer patients with high PD-L1 levels to reduce rapid disease progression

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Testing GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    Bulgaria Czechia France Germany Poland
  • A Study of Migalastat Safety and Effects in Children Aged 2 to 12 Years with Fabry Disease and Suitable Gene Changes

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Belgium Germany Spain
  • Testing OMTX705 Combined with Carboplatin, Pemetrexed, and Tislelizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Spain
  • Study of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    Belgium France Germany Greece Italy The Netherlands +4

powered by